Yayıncı "AMER SOC CLINICAL ONCOLOGY" için listeleme
Toplam kayıt 17, listelenen: 1-17
-
A phase II pilot study of weekly docetaxel cisplatin and 5-fluorouracil in metastatic gastric cancer.
(AMER SOC CLINICAL ONCOLOGY, 2010)… -
Biologic markers guiding the treatment of non-small cell lung cancer: RRM-1, class III beta tubulin, and ERCC-1.
(AMER SOC CLINICAL ONCOLOGY, 2013)… -
Combined versus sequential antracycline and taxane adjuvant regimens in triple negative breast cancer patients.
(AMER SOC CLINICAL ONCOLOGY, 2016)… -
Correlation of high FDG uptake in PET/CT with poor prognosis in metastatic gastric adenocarcinoma.
(AMER SOC CLINICAL ONCOLOGY, 2011)… -
Multicentric ipilimumab experience in Turkish patients with metastatic melanoma: MIPI-TURK at 30 months of follow-up.
(AMER SOC CLINICAL ONCOLOGY, 2013)… -
Multicentric ipilimumab experience in Turkish patients with metastatic melanoma: MIPI-TURK.
(AMER SOC CLINICAL ONCOLOGY, 2012)… -
Outcome in carcinoma of the uterus with papillary serous and clear cell histology: A Turkish Oncology Group Study
(AMER SOC CLINICAL ONCOLOGY, 2008)… -
Postoperative radiotherapy for prostate cancer: Sooner or later?
(AMER SOC CLINICAL ONCOLOGY, 2009)… -
Profile of the colorectal (CRC) cancer (Ca) patients (PTS) in Turkey: A cross-sectional disease registry study-A Turkish Oncology Group trial
(AMER SOC CLINICAL ONCOLOGY, 2011)… -
Prognostic significance of serum thymidine kinase activity (TK1) level in patients with metastatic non-small cell lung cancer (NSCLC)
(AMER SOC CLINICAL ONCOLOGY, 2011)… -
Radiotherapy with or without temozolomide in elderly glioblastoma patients: Treatment results and prognostic factors.
(AMER SOC CLINICAL ONCOLOGY, 2010)… -
Results of the Turkish prospective multi-center study utilizing the 21-gene Oncotype DX assay: Decision impact analysis.
(AMER SOC CLINICAL ONCOLOGY, 2015)… -
The impact of 21-gene recurrence score (RS) scores on treatment decisions: Retrospective evaluation in Turkish early-stage breast cancer (BC) patients
(AMER SOC CLINICAL ONCOLOGY, 2011)… -
What are the differences between young (25 years) and adults (> 25 years) colorectal cancer (CRC)? An Anatolian Society of Medical Oncology Study.
(AMER SOC CLINICAL ONCOLOGY, 2015)…